Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: OTC US
  • Sector: Health Care
  • Industry: Biotech & Pharma
  • Sub-Industry: Large Pharma

ESALF:US

75.0000 USD 2.8663 3.68%

As of 20:10:00 ET on 03/26/2015.

Snapshot for Eisai Co Ltd (ESALF)

Open: 75.0000 Day's Range: 75.0000 - 75.0000 Volume: 991
Previous Close: 77.8663 52wk Range: 35.8500 - 80.1000 1-Yr Rtn: -

Stock Chart for ESALF

No chart data available.
  • ESALF:US 75.0000
  • 1D
  • 1M
  • 1Y
77.8663
Interactive ESALF Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for ESALF

Current P/E Ratio (ttm) -
Estimated P/E(03/2015) 84.8743
Relative P/E vs. SPX -
Earnings Per Share (JPY) (ttm) -
Est. EPS (JPY) (03/2015) 105.7210
Est. PEG Ratio -
Market Cap (M USD) 22,242.52
Shares Outstanding (M) 296.57
30 Day Average Volume 6,212
Price/Book (mrq) -
Price/Sale (ttm) -
Dividend Indicated Gross Yield 1.75%
Cash Dividend (JPY) 80.0000
Dividend Ex-Date 03/27/2015
5 Year Dividend Growth -4.41%
Next Earnings Announcement 05/13/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for ESALF

  • Revenue
  • Net Income (M/JPY)
  • Profit Margin (%)

Company Profile & Key Executives for ESALF

Eisai Co., Ltd. produces prescription drugs and medical equipment and sells mainly to sales agents and subsidiaries. Through its subsidiary, Sanko Junyaku, the Company produces and sells diagnostic drugs. Eisai also markets its products through related companies in the US, Europe, and Asia. The Company also manufactures and sells foods, livestock feeds, chemical, and agrochemicals.

Hideaki MatsuiDirectorNobuo DeguchiDirector
Noboru NaoeDirectorHaruo NaitoRep Corporate Officer/CEO
More Company Profile & Key Executives for ESALF

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil